UA109242U - STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITOR - Google Patents
STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITORInfo
- Publication number
- UA109242U UA109242U UAU201510846U UAU201510846U UA109242U UA 109242 U UA109242 U UA 109242U UA U201510846 U UAU201510846 U UA U201510846U UA U201510846 U UAU201510846 U UA U201510846U UA 109242 U UA109242 U UA 109242U
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- composition containing
- stable pharmaceutical
- proteasom
- inhibitor
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 229940079156 Proteasome inhibitor Drugs 0.000 abstract 2
- 239000003207 proteasome inhibitor Substances 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 208000034578 Multiple myelomas Diseases 0.000 abstract 1
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- 229960001467 bortezomib Drugs 0.000 abstract 1
- GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000008176 lyophilized powder Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Стабільна дозована фармацевтична композиція для лікування множинної мієломи у складі комбінованої терапії, що містить інгібітор протеасом і фармацевтично прийнятні ексципієнти, має форму ліофілізованого порошку для внутрішньовенного введення, причому як інгібітор протеасом містить бортезоміб або його фармацевтично прийнятні гідрат, сольват, безводну форму, складний ефір, тримерну форму.Stable dosage pharmaceutical composition for the treatment of multiple myeloma in combination therapy containing proteasome inhibitor and pharmaceutically acceptable excipients, having the form of a lyophilized powder for intravenous administration, and as a proteasome inhibitor contains bortezomib or its pharmaceutically acceptable hydrate, solvate, solvate three-dimensional shape.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201510846U UA109242U (en) | 2015-11-06 | 2015-11-06 | STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITOR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201510846U UA109242U (en) | 2015-11-06 | 2015-11-06 | STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITOR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA109242U true UA109242U (en) | 2016-08-25 |
Family
ID=56707597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201510846U UA109242U (en) | 2015-11-06 | 2015-11-06 | STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITOR |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA109242U (en) |
-
2015
- 2015-11-06 UA UAU201510846U patent/UA109242U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022001755A (en) | Cyclic di-nucleotide compounds and methods of use. | |
| EA201892395A1 (en) | DRUG COMPOSITIONS OF LSD1 INHIBITOR | |
| EA201792592A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN | |
| TW201613919A (en) | Inhibitors of Bruton's tyrosine kinase | |
| MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
| EA201792591A1 (en) | PHARMACEUTICAL PREPARATIONS | |
| MX2016002580A (en) | Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases. | |
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| MX2016003522A (en) | Quinazoline derivatives and their use as dna methyltransferase inhibitors. | |
| PH12016502243A1 (en) | Pharmaceutical compositions for treating infectious diseases | |
| CY1119532T1 (en) | (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| EA201501164A1 (en) | SOLID PHARMACEUTICAL MEDICINE FORM | |
| MX2022013450A (en) | Pharmaceutical formulations. | |
| MX2019005309A (en) | Anti-bag3 antibodies in combination with inhibitors of immune check-point for therapeutic use. | |
| CY1119522T1 (en) | (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| MX2016008027A (en) | Use of laquinimod to delay huntington's disease progression. | |
| TR201310724A2 (en) | Pharmaceutical formulati̇ons of linagliptin | |
| EA201890929A1 (en) | LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE | |
| MX2017002627A (en) | Derivatives of macrocyclic n-aryl-2-amino-4-aryl-pyrimidine polyethers as inhibitors of ftl3 and jak. | |
| MX2017002544A (en) | Isoquinolinone derivatives useful in the treatment of cancer. | |
| MX2018015759A (en) | Vortioxetine dosing regimes for fast onset of antidepressant effect. | |
| UA109242U (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING PROTEASOM INHIBITOR | |
| MX2016017315A (en) | Pharmaceutical dosage forms. | |
| MX2018013428A (en) | Tablet-in-tablet pharmaceutical composition comprising cyclophosphamide and capecitabine. | |
| MX2017002747A (en) | Derivatives of macrocyclic n-aryl-tricyclopyrimidine-2-amine polyethers as inhibitors of ftl3 and jak. |